| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/29/2006 | WO2006066367A1 Solid lipidic particles as pharmaceutically acceptable fillers or carriers for inhalation |
| 06/29/2006 | WO2006066317A1 Controlled release of biological entities |
| 06/29/2006 | WO2006058029A3 Method of treating opioid dependency |
| 06/29/2006 | WO2006051153A3 Methods and devices for facile fabrication of nanoparticles and their applications |
| 06/29/2006 | WO2006050315A3 Aliphatic amine polymer salts for tableting |
| 06/29/2006 | WO2006047660A3 Methods of acoustic measurement and control of pharmaceutical sprays |
| 06/29/2006 | WO2006039667A3 Water-based delivery systems |
| 06/29/2006 | WO2006026573A3 Biocidal fibrous and film materials utilizing silver ion |
| 06/29/2006 | WO2005112886A3 Methods and articles for the delivery of therapeutic agents |
| 06/29/2006 | WO2005110277A3 Carboxylated polysaccharides and method of preparation and use |
| 06/29/2006 | WO2005105049A3 Orally disintegrating tablets and methods of manufacture |
| 06/29/2006 | WO2005051418A3 Pharmaceutical formulations for the sustained release of interleukins and therapeutic applications thereof |
| 06/29/2006 | WO2005051290A8 Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone |
| 06/29/2006 | WO2005034872A3 Drug-delivery vehicles based on reversed liquid crystalline phase materials |
| 06/29/2006 | WO2005010164A3 Nucleic acid biomaterials and methods of formation and use |
| 06/29/2006 | WO2004093782A3 Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
| 06/29/2006 | WO2004066935A3 Sensitive proteasome sensor constructs and methods for their design and use |
| 06/29/2006 | WO2003106644A3 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations |
| 06/29/2006 | US20060142794 Self-expanding device for the gastrointestinal or urogenital area |
| 06/29/2006 | US20060142374 Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 06/29/2006 | US20060142253 Methods for treating neoplastic, angiogenic, vascular, fibroblastic, and/or immunosuppressive irregularities of the eye and/or joint via administration of combretastatin based medicaments, and iontophoretic devices for delivering combretastatin based medicaments |
| 06/29/2006 | US20060142249 Ophthalmic use |
| 06/29/2006 | US20060142234 Injectable non-aqueous suspension |
| 06/29/2006 | US20060142208 Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs |
| 06/29/2006 | US20060142169 Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 06/29/2006 | US20060141148 Method for modifying microparticles and device for modifying microparticles |
| 06/29/2006 | US20060141128 Process for producing coated preparation |
| 06/29/2006 | US20060141054 Metal coordinated compositions |
| 06/29/2006 | US20060141053 drugs dispersed or coated in a lipid-polymer matrix to mask the bitter or unpleasant taste of drugs |
| 06/29/2006 | US20060141052 Drug microparticles |
| 06/29/2006 | US20060141051 Drug microparticles |
| 06/29/2006 | US20060141050 Drug microparticles |
| 06/29/2006 | US20060141049 Suspended in viscosity modifier (hyaluronic acid) and carrier; sustained release; treating macular edem |
| 06/29/2006 | US20060141048 non-polar polyether covalently linked to an anionic sulfonate group; compounds have an amphipathic quality and preferably, are surface active; useful as surface-active agents to coat and stabilize dispersions of particles in a continuous liquid medium |
| 06/29/2006 | US20060141047 Methods and compositions for delivery of catecholic butanes for treatment of obesity |
| 06/29/2006 | US20060141046 Particles for the delivery of active agents |
| 06/29/2006 | US20060141045 Isolation of cells or the like from bodily fluids |
| 06/29/2006 | US20060141044 Pharmaceutical compositions based on diclofenac derivate |
| 06/29/2006 | US20060141043 Aqueous dispersion comprising stable nanoparticles of a water-insoluble thiazole derivative and excipients like middle chain triglycerides |
| 06/29/2006 | US20060141042 Hollow nanoparticle having modified cysteine residue and drug with the use thereof |
| 06/29/2006 | US20060141041 systemic delivery of labile agent to mammal comprising administering by mouth sustained release composition comprising microparticles containing labile agents, biocompatible polymers, and water soluble polymers, for absorption in the gastrointestinal systems; DNA vaccines |
| 06/29/2006 | US20060141040 Injectable non-aqueous suspension |
| 06/29/2006 | US20060141039 Camellia extract of semi-oxidized tissue and an enhancing agent; for removing dental plaque and/or inhibiting deposition of dental plaque |
| 06/29/2006 | US20060141038 Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2 pyrrolidone/vinyl-acetate |
| 06/29/2006 | US20060141037 Bilayer tablets of oxcarbazepine for controlled delivery and a process of preparation thereof |
| 06/29/2006 | US20060141036 HMG-CoA reductase inhibitor extended release formulation |
| 06/29/2006 | US20060141035 HMG-COA reductase inhibitor extended release formulation |
| 06/29/2006 | US20060141034 GABA analog prodrug sustained release oral dosage forms |
| 06/29/2006 | US20060141033 P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient |
| 06/29/2006 | US20060141032 Effervescent formulations comprising apomorphine |
| 06/29/2006 | US20060141031 Orally disintegrating pharmaceutical compositions with sensory cue agents |
| 06/29/2006 | US20060141030 Method and composition for stable and controlled delivery of (-)-hydroxycitric acid |
| 06/29/2006 | US20060141029 Methods and compositions for delivery of catecholic butanes for treatment of diseases |
| 06/29/2006 | US20060141028 Cyclosporin formulations |
| 06/29/2006 | US20060141027 Sublingual administration of non-steroidal anti-inflammatory pharmacological substances |
| 06/29/2006 | US20060141026 Imprinted paintball and apparatus and method for manufacturing same |
| 06/29/2006 | US20060141025 treating malignant, premalignant or benign tumor arising from or associated with a tissue or organ selected from breast, liver, stomach, pancreas, colorectal, colon and prostate, by administering tetra-O-methyl NDGA and a carrier |
| 06/29/2006 | US20060141024 Synergistic combination kit of alpha,beta-arteether, sulfadoxin and pyrimethamine for treatment of severe/multi-drug resistant cerebral malaria |
| 06/29/2006 | US20060141023 Pharmaceutical compositions containing abiguanide-glitazone combination |
| 06/29/2006 | US20060141022 Soft capsule preparation |
| 06/29/2006 | US20060141021 Polymeric microspheres and method for preparing the same |
| 06/29/2006 | US20060141020 Liposomes containing oligonucleotides |
| 06/29/2006 | US20060141019 Liposome |
| 06/29/2006 | US20060141015 Antimicrobial material |
| 06/29/2006 | US20060141014 Skin treatment articles and methods |
| 06/29/2006 | US20060141009 Novel compositions and processes for delivering an additive |
| 06/29/2006 | US20060141008 Over-coated product including consumable center and medicament |
| 06/29/2006 | US20060141007 Agent with a retarded release of substances |
| 06/29/2006 | US20060141005 Compositions and medical devices utilizing bioabsorbable polymeric waxes |
| 06/29/2006 | US20060141004 Compositions and medical devices utilizing bioabsorbable polymeric waxes |
| 06/29/2006 | US20060140991 Pharmaceutical preparations having an improved solubility |
| 06/29/2006 | US20060140990 Composition for topical treatment of mixed vaginal infections |
| 06/29/2006 | US20060140989 Pharmaceutical formulations |
| 06/29/2006 | US20060140988 Visco-supplement composition and methods |
| 06/29/2006 | US20060140987 Aqueous compositions with poorly water soluble compounds |
| 06/29/2006 | US20060140986 Anesthetic composition for topical administration |
| 06/29/2006 | US20060140985 Lansoprazole formulations and related processes and methods |
| 06/29/2006 | US20060140984 Alcohol-free carrier comprising water, hydrophobic solvent, foam adjuvant of (hydroxyl-substituted and/or unsaturated) fatty alcohols and/or fatty acids; surfactant, and water gelling agent; sensitivity, non-drying; liquefied or compressed gas propellant in container |
| 06/29/2006 | US20060140962 Combination treatment of pancreatic cancer |
| 06/29/2006 | US20060140928 Use of heparinases to decrease inflammatory response |
| 06/29/2006 | US20060140925 Composition of biochemical compounds involved in bioenergy metabolism of cells and method of use |
| 06/29/2006 | US20060140920 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain |
| 06/29/2006 | US20060140917 Compositions and methods for selective dissolution of nascent intravascular blood clots |
| 06/29/2006 | US20060140907 Central airway administration for systemic delivery of therapeutics |
| 06/29/2006 | US20060140904 Random alkylene oxide copolymers for medical and surgical utilities |
| 06/29/2006 | US20060140902 Odor control substrates |
| 06/29/2006 | US20060140876 Buccal cavity treatment composition and corresponding uses thereof |
| 06/29/2006 | US20060140875 Semi-soft C-class immunostimulatory oligonucleotides |
| 06/29/2006 | US20060140874 Stable aerosol formulations of peptides and protein with non-cfc propellants |
| 06/29/2006 | US20060140868 Method of preparation of biomagnetic nanoparticles coated with a noble metal layer |
| 06/29/2006 | US20060140847 Method for introducing functional material into organic nanotube |
| 06/29/2006 | US20060140816 Sterilization of beclomethasone drug particles for pulmonary delivery |
| 06/29/2006 | US20060138687 Method of forming particles |
| 06/29/2006 | DE4321205B4 Mikrokapseln, Verfahren zu ihrer Herstellung und ihre Verwendung Microcapsules, processes for their preparation and their use |
| 06/29/2006 | DE10038110B4 Pharmazeutische Zusammensetzungen Pharmaceutical compositions |
| 06/29/2006 | CA2820728A1 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 06/29/2006 | CA2595517A1 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 06/29/2006 | CA2592474A1 Prostaglandin f2.alpha. derivative-containing product |
| 06/29/2006 | CA2592091A1 Solid pharmaceutical composition comprising valsartan |
| 06/29/2006 | CA2592030A1 Solid dosage form comprising proton pump inhibitor and suspension made thereof |